Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Hair changes can indicate systemic diseases or medication effects.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Folliculitis decalvans was successfully treated with doxycycline and ozenoxacin.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Early identification of lupus through skin signs and blood tests is crucial in India.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.